Evolutionary Therapy News Today

In a study published online ahead of print in Cancer Research, a team of Moffitt Cancer Center researchers introduce a novel framework that leverages deep

Cells constantly navigate a dynamic environment, facing ever-changing conditions and challenges. But how do cells swiftly adapt to these environmental fluctuati

Cells constantly navigate a dynamic environment, facing ever-changing conditions and challenges. But how do cells swiftly adapt to these environmental fluctuati

Doctors diagnosed Christopher Gregg, PhD, member of the Nuclear Control of Cell Growth and Differentiation Program at Huntsman Cancer Institute at the University of Utah and neuroscientist and professor of neurobiology and human genetics at the U, with stage 4 metastatic breast cancer in 2018.

Moffitt Cancer CenterNews, press releases, and expert sources for journalists in science, medicine & business

Doctors diagnosed Christopher Gregg, Ph.D., member of the Nuclear Control of Cell Growth and Differentiation Program at Huntsman Cancer Institute at the University of Utah (the U) and neuroscientist and professor of neurobiology and human genetics at the U, with stage 4 metastatic breast cancer in 2018.

The relatively new discipline of evolutionary medicine is making strides in the fields of cancer treatment and antibacterial resistance.

Damon R. Reed, MD, discusses a phase 2 study of fam-trastuzumab deruxtecan-nxki in adolescent and young adult patients with recurrent HER2-positive osteosarcoma.

Researchers in the Center of Excellence for Evolutionary Therapy at Moffitt Cancer Center have been investigating an alternative treatment approach called adapt

Most cancer treatments are based on using the maximum tolerated dose of a drug to kill as many cancer cells as possible.